Clinical Trial: A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes

U.S., Sept. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07843485) titled 'A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes' on Sept. 11.

Brief Summary: This study will evaluate the efficacy and safety of petrelintide compared with placebo, in conjunction with a reduced-calorie diet and increased physical activity, for weight management in participants living with overweight or obesity and with Type 2 Diabetes (T2D).

Study Start Date: Sept. 30

Study Type: INTERVENTIONAL

Condition: Obesity or Overweight Type 2 Diabetes

Intervention: COMBINATION_PRODUCT: Petrelintide

Petrelintide will be administered subcutaneously (S...